Supply Chain Intelligence

Impact BioMedical Inc. Supply Chain

IBO supply chain intelligence for Impact BioMedical Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

IBO ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

7Suppliers
9Customers
0Debt Items
6Related Chains

Impact BioMedical Inc. Suppliers

TickerNameConfidenceEvidence
DSS-INC DSS-INC 92% In consideration thereof, PubCo agreed to issue to DSS, Inc. the DSS Shares at the Closing, subject to the effectiveness of the registration statement covering such shares.
CHEMIA CHEMIA 90% Based on the Addendum, Chemia should pay the Company 5 % of net sales in royalty.
DSS-BIOHEALTH-SECURITY-INC DSS-BIOHEALTH-SECURITY-INC 85% Schedule I was amended to reflect the updated share ownership of DSS, Inc. and DSS BioHealth Security, Inc.
GRDG-SCIENCES-LLC GRDG-SCIENCES-LLC 80% Licensing Proceeds Distribution Agreement with GRDG Sciences, LLC dated February 15, 2022
PRPH ProPhase Labs, Inc. 80% License Agreement with ProPhase Labs, Inc. dated March 17, 2022
PRPH ProPhase Labs, Inc. 80% Reciprocal relationship from PRPH graph: Reciprocal relationship from IBO graph: License Agreement with ProPhase Labs, Inc. dated March 17, 2022
DSS DSS, Inc. 72% Reciprocal relationship from DSS graph: Reciprocal relationship from IBO graph: Reciprocal relationship from DSS graph: ating segments in 2024 highlight the company’s ongoing commitment to innovation…

Impact BioMedical Inc. Customers

TickerNameConfidenceEvidence
DSS-INC DSS-INC 92% DSS, Inc. agreed to certain funding and hold harmless obligations in connection with the transactions contemplated by the Merger and Share Exchange Agreement
CHEMIA CHEMIA 90% Based on the Addendum, Chemia should pay the Company 5 % of net sales in royalty.
PRPH ProPhase Labs, Inc. 90% In exchange, the Licensee shall pay the Company a royalty of 5.5 % of net sales.
PRPH ProPhase Labs, Inc. 90% Reciprocal relationship from PRPH graph: Reciprocal relationship from IBO graph: Reciprocal relationship from PRPH graph: Reciprocal relationship from IBO graph: In exchange, the Licensee shall pay t…
DSS-BIOHEALTH-SECURITY-INC DSS-BIOHEALTH-SECURITY-INC 85% Schedule I was amended to reflect the updated share ownership of DSS, Inc. and DSS BioHealth Security, Inc.
DSS-PURE-AIR-INC DSS-PURE-AIR-INC 85% uired above market and below market leases, in-place lease value (if applicable). Acquisition-date fair values of assets and assumed liabilities are determined based on replacement costs, appraised v…
LICENSEE LICENSEE 85% In exchange, the Licensee shall pay the Company a royalty of 5.5 % of net sales.
GRDG-SCIENCES-LLC GRDG-SCIENCES-LLC 80% The Company shall reimburse the Licensee for 50 % of the development costs provided that the development costs shall not exceed $ 1,250,000 .
DSS DSS, Inc. 72% Reciprocal relationship from DSS graph: ating segments in 2024 highlight the company’s ongoing commitment to innovation and diversification. Each segment is strategically positioned for growth, with …

Impact BioMedical Inc. Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Impact BioMedical Inc..

Impact BioMedical Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Impact BioMedical Inc..

Impact BioMedical Inc. Ownership

HolderNameConfidenceEvidence
IBO-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 22 tracked holders.

Impact BioMedical Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DSS DSS, Inc. 100.00 1 ['customer', 'supplier']
PRPH ProPhase Labs, Inc. 60.75 1 ['customer', 'supplier']
CHEMIA CHEMIA 60.75 1 ['receiving']
DGX Quest Diagnostics Incorporated 50.00 2
IDXG Interpace Biosciences, Inc. 50.00 2
FISI Financial Institutions, Inc. 23.09 2
View IBO supply chain intel →

Explore the full interactive supply chain map for Impact BioMedical Inc..

Open IBO supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map